Nina Kjellson

Home / Speaker / Nina Kjellson
Responsive image

Nina Kjellson


Nina Kjellson has been part of InterWest’s life sciences team since 2002, focusing primarily on investments in biopharmaceuticals.

She is a board member of Alvine PharmaceuticalsCebixEiger BiopharmaceuticalsLabrysLyceraPrimeraDxTrius Therapeutics(TSRX), Welltok and Xenon. Nina co-sponsored InterWest’s investments in TESARO and Sera Prognostics where she is also a board observer. She also leads InterWest’s initiative in health care IT and is a director of the Consumer Medicine Summit, a forum to address the convergence of health care and consumer innovation, and serves as a mentor to the Nike+ Accelerator and to Blueprint Health.

Prior to joining InterWest, Nina was an investment manager at Bay City Capital, a life sciences merchant bank, and a research associate at Oracle Partners, a health care-focused hedge fund. Nina began her career conducting health policy and survey research with the Kaiser Family Foundation.

Nina received a B.A. in human biology from Stanford University.


Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt